LIPOCINE INC. : Other Events, Financial Statements and Exhibits (form 8-K)

Item 8.01 Other Events

On January 14, 2021, the Company issued a press release announcing USPTO declaration of interference between Lipocine and Clarus patent applications. The press release is filed as Exhibit 99.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits.

(d)    Exhibits

The following exhibits are filed with this report:

Exhibit No.    Description

  99.1           Press Release announcing USPTO Declaration of Interference
               Between Lipocine and Clarus Patent Applications

© Edgar Online, source Glimpses